Guanidinoacetic Acid With Creatine Compared With Creatine Alone for Tissue

Status Completed

Clinical Trial Summary

Co-administration of creatine and guanidinoacetic acid (GAA) has been recently put forward as an advanced dietary strategy to optimize tissue bioenergetics. The investigators hypothesized that creatine-GAA mixture would result in more powerful rise in brain and skeletal muscle creatine, as compared to creatine supplementation alone.

Clinical Trial Description

Targeting energy-demanding tissues in health and disease continues to be a challenging task in human nutrition and biomedicine. Impaired bioenergetics accompanies many different conditions, including cardiometabolic diseases, neurodegenerative disorders or high-intensity exercise, with various dietary interventions developed to restore cellular energy. Creatine is recognized as a beneficial and safe energy-boosting agent in both athletic and clinical environments. However, its effectiveness in specific conditions seems to be fairly restrained due to its limits in transportability and performance. Guanidinoacetic acid (GAA), a metabolic precursor of creatine, appears as a novel energy-enhancing supplement, with GAA being superior to creatine in facilitating creatine concentrations in the human brain and skeletal muscle. This perhaps happens due to GAA interaction with cellular transporters previously dismissed as untargetable carriers by other similar therapeutics. On the other hand, GAA loading remains under scrutiny due to its hyperhomocysteinemia-inducing potential, and possible neurotoxic effects. Co-administration of creatine and GAA has been recently proposed as a better strategy comparing to administration of each compound per se. Besides providing a competitive advantage for enhanced levels of tissue creatine, GAA-creatine mixture might also diminish side effects related to isolated GAA administration. However, no human studies so far evaluated the effects of this mixture. In the present study, the investigators compared the impact of 4-week co-administration of GAA and creatine vs. creatine administration alone on serum biomarkers, exercise performance and tissue bioenergetics in healthy young men. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT03350282
Study type	Interventional
Source	University of Novi Sad, Faculty of Sport and Physical Education
Contact
Status	Completed
Phase	N/A
Start date	December 1, 2016
Completion date	May 1, 2018

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04935983` - Maximal Fat Oxidation During Exercise	N/A
Completed	`NCT04114175` - Spinal Stabilization Exercises in Individuals With Transtibial Amputatıon	N/A
Suspended	`NCT00823329` - Calorie Balance Monitoring and Analysis of Body Composition and Hydration Status	Phase 0
Terminated	`NCT03929302` - Brain Energy Metabolism and Sleep in Adults	N/A
Completed	`NCT03701867` - Muscle Energy Metabolism and Metabolic Flexibility in Older Men and Women	N/A
Completed	`NCT04477018` - 16 Weeks' Dietary Supplementation With Iron and Iron + Vitamin C on Cerebral Blood Flow and Energy Expenditure in Women of Reproductive Age	N/A
Recruiting	`NCT05919979` - Effect of a Physical Exercise Session Performed During a 24-34 Hour Fasting Period on Energy Metabolism and Cognitive Function in Healthy Adults	N/A
Completed	`NCT03489226` - Capsimax Effect on Metabolic Rate, Satiety and Food Intake	N/A
Completed	`NCT05523830` - Estimation of Energy Expenditure and Physical Activity Classification With Wearables
Completed	`NCT03550820` - Energy Metabolism for the Patients With Pulmonary Mycobacterium Avium Complex
Completed	`NCT03917212` - Energy Metabolism in Branched-chain Organic Acidemias
Completed	`NCT00853060` - Energy Expenditure in Weaning From Mechanical Ventilation	N/A
Recruiting	`NCT05736302` - Validating a New Machine-Learned Accelerometer Algorithm Using Doubly Labeled Water
Recruiting	`NCT06252077` - Very Low Ketogenic Diet and Energy Expenditure	N/A
Completed	`NCT04320446` - Caffeine Increases Maximal Fat Oxidation During Exercise in Endurance-trained Men: is There a Diurnal Variation	N/A
Completed	`NCT03678116` - Effects of a Thermogenic Dietary Supplement on Metabolic, Hemodynamic, and Mood Responses	N/A
Completed	`NCT05703100` - Lactate Profile and Fat Oxidation During Exercise	N/A
Completed	`NCT01209572` - Modelling of Energy Expenditure From Heart Rate, Accelerometry and Other Physiological Parameters	N/A
Completed	`NCT03121885` - Human Metabolic Dynamics at Rest and During Aerobic Exercise Under Normobaric Normoxic and Moderate Hypoxic Conditions	N/A
Recruiting	`NCT06230900` - Mass Balance of Orally Administered [14C] (3S,4S,5R)-1,3,4,5,6-pentahydroxy-hexan-2-one	N/A

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Guanidinoacetic Acid With Creatine Compared With Creatine Alone for Tissue Bioenergetics, Hyperhomocysteinemia and Exercise Performance

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms